GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Dipna Pharmachem Ltd

Dipna Pharmachem FY26 Net Profit Rises to Rs. 263.19 Lakhs

RESULTS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 02 Jul 2026, 09:18 PM IST  ·  BSE ID: e35a63d7-2a5a-4907-9e3d-a80064ff82bc
View Original BSE Filing (PDF)
💡
In Simple Terms
The company announced its annual financial results, showing a net profit of Rs. 263.19 Lakhs for the year.
🤖 AI Summary
  • Board approved Audited Financial Results for the Quarter and Year ended March 31, 2026.
  • Net profit for the year ended March 31, 2026, was Rs. 263.19 Lakhs.
  • Total revenue from operations for FY26 stood at Rs. 12,908.33 Lakhs.
  • Basic Earnings Per Share for FY26 was reported as Rs. 1.00.
  • Board approved Statement of Deviations/Variations for Preferential Issue – Convertible Warrants proceeds.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Net profit for the year ended March 31, 2026
Rs. 263.19 Lakhs
170.22
Revenue from operations for the year ended March 31, 2026
Rs. 12,908.33 Lakhs
3.33
Basic Earning per equity share (FY26)
Rs. 1.00
143.90
Total Assets as at March 31, 2026
Rs. 20,562.94 Lakhs
55.35
🏢 How This Affects the Company
📈
Business Impact
The company's revenue from operations for the year ended March 31, 2026, was Rs. 12,908.33 Lakhs, indicating sustained operational scale in its Chemical and Steel segments.
💰
Financial Impact
Net profit for FY26 was Rs. 263.19 Lakhs, a substantial increase from Rs. 97.40 Lakhs in the previous year. Total assets grew to Rs. 20,562.94 Lakhs as of March 31, 2026, from Rs. 13,238.03 Lakhs a year prior.
⚙️
Operational Impact
The company has adopted IND AS for the first time, aligning its financial reporting with Indian Accounting Standards. Segment reporting confirms two segments: Chemicals and Steel, with Steel segment revenue at Rs. 7,089.14 Lakhs for FY26.
⚠️
Risk Impact
The Statement of Deviations/Variations for Preferential Issue proceeds has been approved, confirming compliance with Regulation 32 of SEBI (LODR) Regulations, 2015 regarding fund utilization.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance. Basic EPS increased to Rs. 1.00 for FY26 from Rs. 0.41 in FY25, reflecting improved profitability.
🔍
Management Signal
The Board's approval of the audited financial results and the Statement of Deviations/Variations for the Preferential Issue indicates adherence to regulatory compliance and transparent financial disclosure.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q1 FY27 results — monitor revenue and profitability trends across segments.
Updates on segment performance — observe if Chemicals Segment returns to profitability.
Utilization of Preferential Issue proceeds — track the impact on future growth.
MEDIUM RISK The negative cash flow from operations and losses in the Chemicals segment present operational and liquidity challenges.
💡 Investor Takeaway
Dipna Pharmachem's net profit for the year ended March 31, 2026, was Rs. 263.19 Lakhs, up from Rs. 97.40 Lakhs in the previous year. Total revenue from operations stood at Rs. 12,908.33 Lakhs. Basic EPS for FY26 was Rs. 1.00.
⚖️ Strengths & Concerns

✅ Positives

  • Net profit for the year ended March 31, 2026, significantly increased to Rs. 263.19 Lakhs from Rs. 97.40 Lakhs in the previous year.
  • Total assets grew by 55.35% to Rs. 20,562.94 Lakhs as of March 31, 2026, from Rs. 13,238.03 Lakhs last year.

⚠️ Concerns

  • Cash generated from operations for FY26 was negative Rs. 1,740.57 Lakhs, indicating ongoing working capital requirements.
  • The Chemicals Segment reported a negative result of (Rs. 512.35) Lakhs for FY26, contrasting with the positive result of Rs. 124.30 Lakhs in the previous year.
📅 Company Track Record
Dipna Pharmachem's FY26 net profit of Rs. 263.19 Lakhs marks a substantial increase from FY25's net profit of Rs. 97.40 Lakhs, as per past filings. Revenue from operations also saw a modest increase from Rs. 12,491.71 Lakhs in FY25.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Dipna Pharmachem's net profit for the year ended March 31, 2026?
Dipna Pharmachem's net profit for the year ended March 31, 2026, was Rs. 263.19 Lakhs.
What was Dipna Pharmachem's revenue from operations for FY26?
The revenue from operations for Dipna Pharmachem for the year ended March 31, 2026, was Rs. 12,908.33 Lakhs.
What was the Basic Earnings Per Share (EPS) for Dipna Pharmachem for FY26?
The Basic Earnings Per Share for Dipna Pharmachem for the year ended March 31, 2026, was Rs. 1.00.
How did Dipna Pharmachem's total assets change as of March 31, 2026?
Dipna Pharmachem's total assets increased to Rs. 20,562.94 Lakhs as of March 31, 2026, from Rs. 13,238.03 Lakhs as of March 31, 2025.
What was the result of Dipna Pharmachem's Chemicals Segment for FY26?
The Chemicals Segment of Dipna Pharmachem reported a result of (Rs. 512.35) Lakhs for the year ended March 31, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.